Clinical Trials · NCT06291064
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Chicago
- Enrollment
- 85
- Start date
- Mar 2025
- Locations
- 4 sites, Nigeria
- Primary endpoint
- Percentage of Participants that Achieve Pathologic Complete Response (pCR) Rate (Breast)